When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Dipeptidyl peptidase-4 inhibitor - Wikipedia

    en.wikipedia.org/wiki/Dipeptidyl_peptidase-4...

    DPP-4 inhibitors and GLP-1. Inhibitors of dipeptidyl peptidase 4 (DPP-4 inhibitors or gliptins) are a class of oral hypoglycemics that block the enzyme dipeptidyl peptidase-4 (DPP-4). They can be used to treat diabetes mellitus type 2. The first agent of the class – sitagliptin – was approved by the FDA in 2006. [1]

  3. Discovery and development of dipeptidyl peptidase-4 inhibitors

    en.wikipedia.org/wiki/Discovery_and_development...

    It used thiazolidide as the P1-substitute and was the first DPP-4 inhibitor that showed effects in both animals and humans but it was not developed to a market drug due to side effects. Another old inhibitor is DPP-728 from Novartis, where 2-cyanopyrrolidine is used as the P1-substitute. The addition of the cyano group generally increases the ...

  4. Category:Dipeptidyl peptidase-4 inhibitors - Wikipedia

    en.wikipedia.org/wiki/Category:Dipeptidyl...

    Pages in category "Dipeptidyl peptidase-4 inhibitors" The following 22 pages are in this category, out of 22 total. This list may not reflect recent changes. ...

  5. Vildagliptin - Wikipedia

    en.wikipedia.org/wiki/Vildagliptin

    Vildagliptin, sold under the brand name Galvus and others, is an oral anti-hyperglycemic agent (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs.

  6. Alogliptin - Wikipedia

    en.wikipedia.org/wiki/Alogliptin

    Alogliptin, sold under the brand names Nesina and Vipidia, [2] [3] is an oral anti-diabetic drug in the DPP-4 inhibitor (gliptin) class. [4] Like other members of the gliptin class, it causes little or no weight gain, exhibits relatively little risk of hypoglycemia, and has relatively modest glucose-lowering activity. [1]

  7. Fotagliptin - Wikipedia

    en.wikipedia.org/wiki/Fotagliptin

    Fotagliptin (SAL067) is a DPP-4 inhibitor under development for the treatment of type 2 diabetes. Like other DPP-4 inhibitors, it works by increasing endogenously produced GLP-1 and GIP . [ 1 ] [ 2 ] [ 3 ] In a phase 3 trial it showed similar results as alogliptin .

  8. Category:Anti-diabetic drugs - Wikipedia

    en.wikipedia.org/wiki/Category:Anti-diabetic_drugs

    Generally, drugs outlined within the ATC code A10 should be included in this category. ... Dipeptidyl peptidase-4 inhibitors (22 P) E. Experimental diabetes drugs (29 ...

  9. Dipeptidyl peptidase-4 - Wikipedia

    en.wikipedia.org/wiki/Dipeptidyl_peptidase-4

    A class of oral hypoglycemics called dipeptidyl peptidase-4 inhibitors works by inhibiting the action of this enzyme, thereby prolonging incretin effect in vivo. [18] Middle East respiratory syndrome coronavirus has been found to bind to DPP4. It is found on the surface of cells in the airways (such as the lungs) and kidneys.